Sunday, April 10, 2022

Medical Directors Report 4-2022

 Report 4-2022

CMS Waivers Expiring

Update on Aspirin for Primary Prevention -- ASPREE, ARRIVE, ASCEND Trials

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.